Skip to Content

Jiangsu Lianhuan Pharmaceutical Co Ltd Class A 600513

Morningstar Rating
CNY 9.41 −0.07 (0.74%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

600513 is trading at a 229% premium.
Price
CNY 9.45
Fair Value
CNY 91.17
Uncertainty
Very High
1-Star Price
CNY 52.71
5-Star Price
CNY 2.98
Economic Moat
Lxv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 600513 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 9.48
Day Range
CNY 9.319.57
52-Week Range
CNY 6.7114.40
Bid/Ask
CNY 9.41 / CNY 9.42
Market Cap
CNY 2.69 Bil
Volume/Avg
6.2 Mil / 7.3 Mil

Key Statistics

Price/Earnings (Normalized)
23.32
Price/Sales
1.21
Dividend Yield (Trailing)
1.59%
Dividend Yield (Forward)
1.59%
Total Yield
1.59%

Company Profile

Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
1,296

Comparables

Valuation

Metric
600513
002262
300254
Price/Earnings (Normalized)
23.3223.61
Price/Book Value
1.943.563.62
Price/Sales
1.214.602.77
Price/Cash Flow
17.2127.3927.99
Price/Earnings
600513
002262
300254

Financial Strength

Metric
600513
002262
300254
Quick Ratio
0.685.890.57
Current Ratio
1.106.650.93
Interest Coverage
7.70244.443.80
Quick Ratio
600513
002262
300254

Profitability

Metric
600513
002262
300254
Return on Assets (Normalized)
4.20%14.72%−0.33%
Return on Equity (Normalized)
8.84%16.82%−0.88%
Return on Invested Capital (Normalized)
6.41%16.43%1.27%
Return on Assets
600513
002262
300254
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ABnzptrpmdPrdt$79.4 Bil
MKKGY
Merck KGaA ADRVxgnkfpmxYwwfzf$79.0 Bil
HLN
Haleon PLC ADRDrnbgwyMhch$38.5 Bil
VTRS
Viatris IncBygqlmdntTrpl$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMzltjvjjJttlq$11.7 Bil
CTLT
Catalent IncYhhnqdjxxBwdrst$10.0 Bil
CURLF
Curaleaf Holdings IncKflxjzbybXdx$4.2 Bil
PRGO
Perrigo Co PLCXgmrstlYsyw$4.1 Bil
PBH
Prestige Consumer Healthcare IncNgwvrlfYhywdr$3.2 Bil
GTBIF
Green Thumb Industries IncNwnqgtvrkQvps$3.1 Bil

Sponsor Center